The Senior Director of Marketing & Market Development will play an integral role in bringing our groundbreaking AAV gene therapies to patients with genetic cardiomyopathies. In this high-impact role, the incumbent will build Lexeo’s marketing function from the ground up, shaping brand strategy, market development, and launch readiness for first-in-class therapies poised to transform care in cardiac genetic diseases with high unmet need. You’ll combine strategic vision with hands-on execution, crafting compelling scientific narratives, driving disease awareness, and preparing providers, patients, and payers for a new era in gene therapy. This is a rare opportunity to define how life-changing science becomes real-world medicine.
The Senior Director of Marketing & Market Development will play an integral role in bringing our groundbreaking AAV gene therapies to patients with genetic cardiomyopathies. In this high-impact role, the incumbent will build Lexeo’s marketing function from the ground up, shaping brand strategy, market development, and launch readiness for first-in-class therapies poised to transform care in cardiac genetic diseases with high unmet need. You’ll combine strategic vision with hands-on execution, crafting compelling scientific narratives, driving disease awareness, and preparing providers, patients, and payers for a new era in gene therapy. This is a rare opportunity to define how life-changing science becomes real-world medicine.
Primary Responsibilities
Build, lead, and scale the marketing function; manage budget, resources, vendor/agency relationships, and KPIs tied to demand generation and launch readiness
Develop and execute integrated brand and marketing strategies for Lexeo’s cardiac pipeline(initially US-focused and future global expansion)
Shape and evolve Lexeo’s brand story as a leader in genetic cardiovascular medicine, partner with external communications (media, PR, social, thought leadership, IR)
Build deep customer segmentation and personas across key stakeholders: opinion leaders, cardiologists, genetic specialists, patient advocacy groups, and other members of multi-disciplinary care teams
Lead disease awareness and diagnosis-activation initiatives in partnership with Medical and Patient Affairs
Define evidence needs and value propositions for payer engagement, pricing, and provider strategies
Contribute to strategic planning and commercial prioritization across the portfolio
Develop messaging frameworks for HCPs, patients, and payers, emphasizing genetic causes, durability, and impact of therapies.
Expand Lexeo commercial infrastructure with an eye towards commercial launches, including data and analytics, field reporting, patient support and commercial intelligence
Serve as the commercial voice on cross-functional teams, ensuring alignment from early stage through launch
Collaborate with new and growing field teams, including market access, medical affairs, field reimbursement and sales
Required Skills & Qualifications
Bachelor’s in Life Sciences, Marketing, or Business required; MBA, PharmD, or PhD preferred.
10+ years in life sciences marketing (rare disease, gene therapy, advanced biologics), with both upstream (strategy, portfolio) and downstream (brand, digital) experience.
Experience in developing launch readiness for novel therapies (cell/gene therapies, biologics in rare/monogenic disease); experience in specialty/high-science areas is preferred
Strong scientific acumen; familiarity with AAV platforms, manufacturing, and regulatory pathways.
Deep competency in digital/omnichannel marketing: CRM, automation, SEO/SEM, analytics, content strategy.
Strong cross-functional collaboration skills and ability to influence senior leadership
Ability to translate complex science into compelling commercial narratives
About Lexeo
Lexeo Therapeutics is a clinical-stage genetic medicine company headquartered in New York City, pioneering cardiac genetic medicine candidates to treat the root causes of inherited cardiovascular diseases. Our lead program, LX2006, targets cardiomyopathy associated with Friedreich’s Ataxia and anchors a broader pipeline addressing genetically defined conditions such as hypertrophic and arrhythmogenic cardiomyopathies. Backed by a strong financial foundation, Lexeo is positioned to translate groundbreaking science into durable clinical impact.
Our work culture is a hybrid model with 2 days/week in the New York City office and 3 days working from home.
Lexeo Therapeutics is an EEO employer committed to an exciting, diverse, and enriching work environment.
Estas cookies son necesarias para que el sitio web funcione y no se pueden desactivar en nuestros sistemas. Puede configurar su navegador para bloquear estas cookies, pero entonces algunas partes del sitio web podrían no funcionar.
Seguridad
Experiencia de usuario
Cookies orientadas al público objetivo
Estas cookies son instaladas a través de nuestro sitio web por nuestros socios publicitarios. Estas empresas pueden utilizarlas para elaborar un perfil de sus intereses y mostrarle publicidad relevante en otros lugares.
Google Analytics
Anuncios Google
Utilizamos cookies
🍪
Nuestro sitio web utiliza cookies y tecnologías similares para personalizar el contenido, optimizar la experiencia del usuario e indvidualizar y evaluar la publicidad. Al hacer clic en Aceptar o activar una opción en la configuración de cookies, usted acepta esto.
Los mejores empleos remotos por correo electrónico
¡Únete a más de 5.000 personas que reciben alertas semanales con empleos remotos!